Furthermore, NSCLC patients exhibited significantly increased phosphorylation levels of JAK1, and its high expression correlated with unfavorable prognosis, emphasizing the utility of phosphorylated JAK1 as a predictive marker for NSCLC treatment (31). The gene discussed is JAK1; the disease is non-small cell lung carcinoma.